FDAnews
www.fdanews.com/articles/72958-j-j-to-bring-in-new-line-of-treatment-for-blood-cancer

J&J to Bring in New Line of Treatment for Blood Cancer

June 3, 2005

For patients with multiple myeloma, a type of blood cancer, a new line of treatment is slated to be available in India by August. Velcade (bortezomib) has got clearance from the Indian regulatory authorities and the drug will be brought into India by Janssen-Cilag, part of Johnson and Johnson (J&J). Significantly, approval for Velcade had been fast-tracked by the U.S. regulatory authority, given its results during the clinical trials.

()a href="http://www.thehindubusinessline.com/2005/06/03/stories/2005060303041000.htm" target="_blank">The Hindu